Abstract
The efficient discovery of novel drug modalities, which are rapidly diversifying, requires a digital transformation of discovery processes. While robotics and informatics methods have been introduced over the past years, the transformation can be achieved by smoothly combining them with each other, incorporating the recent innovative advances in artificial intelligence. At the current level of technology, collaboration between humans and artificial intelligence, and between humans and robots, are important, and it is essential not only to introduce technology, but also to create mechanisms to encourage this collaboration. We are transforming the entire discovery process, starting with the discovery of small molecule modalities. By applying similar approach to other modality research in the future, we believe that we can further improve the productivity for the discovery of a wide variety of drug modalities.
